Tissue Response: Biomaterials, Dental Implants, and Compromised Osseous tissue

Dental Clinics of North America

Volumn 59, Issue 2, 2015, Pages 305-315

  Babu, R S Arvind ^a   Ogle, Orrett ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

Biomaterials; Dental implants; Osseous lesions; Tissue response

Indexed keywords

BIOMATERIAL; DENTAL MATERIAL; TOOTH IMPLANT;

ANATOMY AND HISTOLOGY; BONE DISEASE; BONE IMPLANT INTERFACE; BONE REGENERATION; CHEMISTRY; CHRONIC DISEASE; HUMAN; PATHOLOGY; PATHOPHYSIOLOGY; PATIENT SELECTION; PHYSIOLOGY; TOOTH IMPLANT; WOUND HEALING;

BIOCOMPATIBLE MATERIALS; BONE DISEASES; BONE-IMPLANT INTERFACE; CHRONIC DISEASE; DENTAL IMPLANTS; DENTAL MATERIALS; HUMANS; OSSEOINTEGRATION; PATIENT SELECTION; WOUND HEALING;

EID: 84937513594     PISSN: 00118532     EISSN: 15580512     Source Type: Journal    
DOI: 10.1016/j.cden.2014.10.010     Document Type: Review

References (64)

1. Park J., Lakes R.S. Biomaterials an introduction. Tissue response to implants 2007, 265-290. Springer, New York. 3rd edition.
2. Anderson J.M. Biological responses to materials. Annu Rev Mater Res 2001, 31:81-110.
3. Clark R.A., Henson P.M. The molecular and cellular biology of wound repair 1996, 3-10. Springer, New York. 2nd edition.
4. Kumar V., Abbas A.K., Aster J. Robbins basic pathology 2013, 29-74. Elsevier, Philadelphia. 8th edition.
5. Tang L. Mechanisms of fibrinogen domains: biomaterial interactions. JBiomater Sci Polym Ed 1998, 9:1257-1266.
6. Villar C.C., Huynh-Ba G., Mills M.P., et al. Wound healing around dental implants. Endod Topics 2011, 25:44-62.
7. Shaw T.J., Martin P. Wound repair at a glance. JCell Sci 2009, 122:3209-3213.
8. Broadley K.N., Aquino A.M., Woodward S.C., et al. Monospecific antibodies implicate basic fibroblast growth factor in normal wound repair. Lab Invest 1989, 61:571-575.
9. Ratner B.D., Hoffman A.S., Schoen F.J., et al. Biomaterials science: an introduction to materials in medicine 2013, 503-511. Elsevier, Oxford (UK). 3rd edition.
10. Henson P.M. The immunologic release of constituents from neutrophil leukocytes. II. Mechanisms of release during phagocytosis, and adherence to nonphagocytosable surfaces. JImmunol 1971, 107:1547-1557.
11. Katzenmeyer K.N., Bryers J.D. Multivalent artificial opsonin for the recognition and phagocytosis of gram-positive bacteria by human phagocytes. Biomaterials 2011, 32:4042-4051.
12. Bridges A.W., Whitmire R.E., Singh N., et al. Chronic inflammatory responses to microgel based implant coatings. JBiomed Mater Res 2010, 94:252-258.
13. Tang L., Eaton J.W. Inflammatory responses to biomaterials. Am J Clin Pathol 1995, 103:466-471.
14. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 2008, 20:88-100.
15. Albrektsson T., Dahlin C., Jemt T., et al. Is marginal bone loss around oral implants the result of a provoked foreign body reaction?. Clin Implant Dent Relat Res 2013, 10.1111/cid.12142.
16. Grainger D.W. All charged up about implanted biomaterials. Nat Biotechnol 2013, 31:507-509.
17. Higgins D.M., Basaraba R.J., Hohnbaum A.C., et al. Localized immunosuppressive environment in the foreign body response to implanted biomaterials. Am J Pathol 2009, 175:161-170.
18. Johnson R., Harrison D., Tucci M., et al. Fibrous capsule formation in response to ultrahigh molecular weight polyethylene treated with peptides that influence adhesion. Biomed Sci Instrum 1997, 34:47-52.
19. Fini M., Giavaresi G., Torricelli P., et al. Osteoporosis and biomaterial osteointegration. Biomed Pharmacother 2004, 58:487-493.
20. Rigo E.C., Boschi A.O., Yoshimoto M., et al. Evaluation invitro and invivo of biomimetic hydroxyapatite coated on titanium dental implants. Mater Sci Eng C Mater Biol Appl 2004, 24:647-651.
21. Soballe K. Hydroxyapatite ceramic coating for bone implant fixation. Mechanical and histological studies in dogs. Acta Orthop Scand Suppl 1993, 255:1-58.
22. Davies J.E. Mechanisms of endosseous integration. Int J Prosthodont 1998, 11:391-401.
23. Berglundh T., Abrahamsson I., Lang N.P., et al. De novo alveolar bone formation adjacent to endosseous implants. Clin Oral Implants Res 2003, 14:251-262.
24. Meyer U., Joos U., Mythili J., et al. Ultrastructural characterization of the implant/bone interface of immediately loaded dental implants. Biomaterials 2004, 25:1959-1967.
25. Mavrogenis A.F., Dimitriou R., Parvizi J., et al. Biology of implant osseointegration. JMusculoskelet Neuronal Interact 2009, 9:61-71.
26. Murai K., Takeshita F., Ayukawa Y., et al. Light and electron microscopic studies of bone-titanium interface in the tibiae of young and mature rats. JBiomed Mater Res 1996, 30:523-533.
27. Neville D., Allen B. Fibro osseous lesions. Oral and maxillofacial pathology 2002, 553-556. Elsevier, Philadelphia. 2nd edition.
28. Prabhu N., Duckmanton N., Stevenson A.R., et al. The placement of osseointegrated dental implants in a patient with type IV B osteogenesis imperfecta: a 9-year follow-up. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007, 103:349-354.
29. Payne M.A., Postlethwaite K.R., Smith D.G., et al. Implant-supported rehabilitation of an edentate patient with osteogenesis imperfecta: a case report. Int J Oral Maxillofac Implants 2008, 23:947-952.
30. Binger T., Rücker M., Spitzer W.J. Dentofacial rehabilitation by osteodistraction, augmentation and implantation despite osteogenesis imperfecta. Int J Oral Maxillofac Surg 2006, 35:559-562.
31. Lee C.Y., Ertel S.K. Bone graft augmentation and dental implant treatment in a patient with osteogenesis imperfecta: review of the literature with a case report. Implant Dent 2003, 12:291-295.
32. Misch C.E. Medical evaluation of the dental implant patient. Contemporary implant dentistry 2008, 421-466. Elsevier, Canada. 3rd edition.
33. Flannagan D., Mancini M. Bimaxillary full arch fixed dental implant supported treatment for a patient with renal failure and secondary hyperparathyroidism and osteodystrophy. JOral Implantol 2013, 10.1563/AAID-JOI-D-13-00188.
34. Mori H., Manabe M., Kurachi Y., et al. Osseointegration of dental implants in rabbit bone with low mineral density. JOral Maxillofac Surg 1997, 55:351-361.
35. Heersche J.N., Bellows C.G., Ishida Y. The decrease in bone mass associated with aging and menopause. JProsthet Dent 1998, 79:14-16.
36. Dao T.T., Anderson J.D., Zarb G.A. Is osteoporosis a risk factor for osseointegration of dental implants?. Int J Oral Maxillofac Implants 1993, 8:137-144.
37. Beikler T., Flemming T.F. Implants in the medically compromised patient. Crit Rev Oral Biol Med 2003, 14:305-316.
38. Holahan C.M., Koka S., Kennel K.A., et al. Effect of osteoporotic status on the survival of titanium dental implants. Int J Oral Maxillofac Implants 2008, 23:905-910.
39. Shibli J.A., Aquiar K.C., Melo L., et al. Histologic analysis of human perii-implant bone in type 1 osteoporosis. JOral Implantol 2008, 34:12-16.
40. Fujimoto T., Niimi A., Nakai H., et al. Osseointegrated implants in a patient with steoporosis: a case report. Int J Oral Maxillofac Implants 1996, 11:539-542.
41. Fujimoto T., Niimi A., Sawai T., et al. Effects of steroidinduced osteoporosis on osseointegration of titanium implants. Int J Oral Maxillofac Implants 1998, 13:183-189.
42. Eder A., Watzek G. Treatment of a patient with severe osteoporosis and chronic polyarthritis with fixed implant-supported prosthesis: a case report. Int J Oral Maxillofac Implants 1999, 14:587-590.
43. Friberg B. Treatment with dental implants in patients with severe osteoporosis: a case report. Int J Periodontics Restorative Dent 1994, 14:348-353.
44. Blomqvist J.E., Alberius P., Isaksson S., et al. Factors in implant integration failure after bone grafting: an osteometric and endocrinologic matched analysis. Int J Oral Maxillofac Surg 1999, 25:63-68.
45. August M., Chung K., Chang Y., et al. Influence of estrogen status on endosseous implant osseointegration. JOral Maxillofac Surg 2001, 59:1285-1289.
46. Monje A., Monje F., Suarez F., et al. Oral rehabilitation with dental implants for teeth involved in a maxillary firbous dsyplasia. Clin Adv Periodontics 2013, 3:208-213.
47. Bajwa M.S., Ethunandan M., Flood T.R. Oral rehabilitation with endosseous implants in a patient with fibrous dysplasia (McCune-Albright syndrome): a case report. JOral Maxillofac Surg 2008, 66:2605-2608.
48. Dobbs R.N., S A., Lee J.S. Indications for and management of implants in children. Selected Readings in Oral & Maxillofacial Surgery 2010, 18:1-20.
49. Lee J.S., FitzGibbon E.J., Chen Y.R., et al. Clinical guidelines for the management of craniofacial fibrous dysplasia. Orphanet J Rare Dis 2012, 7:S2.
50. Bencharit S., Schardt-Sacco D., Zuniga J.R., et al. Surgical and prosthodontic rehabilitation for a patient with aggressive florid cemento-osseous dysplasia: a clinical report. JProsthet Dent 2003, 90:220-224.
51. Gerlach R.C., Dixon D.R., Goksel T., et al. Case presentation of florid cemento-osseous dysplasia with concomitant cemento-ossifying fibroma discovered during implant explantation. Oral Surg Oral Med Oral Pathol Oral Radiol 2013, 115:e44-e52.
52. Heymann D., Ory B., Gouin F., et al. Bisphosphonates: new therapeutic agents for the treatment of bone tumors. Trends Mol Med 2004, 10:337-343.
53. Wood J., Bonjean K., Ruetz S., et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. JPharmacol Exp Ther 2002, 302:1055-1061.
54. Flichy Fernandez A.J., Balaguer Martinez J., Penarrocha Diago M., et al. Bisphosphonates and dental implants: current problems. Med Oral Pathol Oral Cir Bucal 2009, 14:E355-E360.
55. Grant B.T., Amenedo C., Freeman K., et al. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases. JOral Maxillofac Surg 2008, 66:223-320.
56. Palaska P.K., Cartsos V., Zavras A.I. Bisphosphonates and time to osteonecrosis development. Oncologist 2009, 14:1154-1166.
57. Meraw S.J., Reeve C.M., Wollan P.C. Use of alendronate in periimplant defect regeneration. JPeriodontol 1999, 70:151-158.
58. Wang H.L., Weber D., McCauley L.K. Effect of long-term oral bisphosphonates on implant wound healing: literature review and a case report. JPeriodontol 2007, 78:584-594.
59. Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. JOral Maxillofac Surg 2007, 65:369-376.
60. Rasmussen J.M., Hopfensperger M.L. Placement and restoration of dental implants in a patient with Paget's disease in remission: literature review and clinical report. JProsthodont 2008, 17:35-40.
61. Torres J., Tamimi F., Garcia I., et al. Dental implants in a patient with Paget disease under bisphosphonate treatment: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009, 107:387-392.
62. Sager R.D., Theis R.M. Dental implants placed in a patient with multiple myeloma: report of case. JAm Dent Assoc 1990, 121:699-701.
63. Granstrom G. Placement of dental implants in irradiated bone: the use for using hyperbaric oxygen. JOral Maxillofac Surg 2006, 64:812-818.
64. Buddula A., Assad D.A., Salinas T.J., et al. Survival of dental implants in native and grafted bone in irradiated head and neck cancer patients: a retrospective analysis. Indian J Dent Res 2011, 22:644-648.